EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access

Wearable Device–Based Intervention for Promoting Patient Physical Activity After Lung Cancer Surgery

Junghee Lee, Sunga Kong, Sumin Shin, Genehee Lee, Hong Kwan Kim, Young Mog Shim, Juhee Cho, Danbee Kang, Hye Yun Park

JAMA Network Open · 20.09.2024 · 7 (9) · e2434180

DOI: 10.1001/jamanetworkopen.2024.34180 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift JAMA Network Open, online erschienen am 20.09.2024. Verfasst von Junghee Lee und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Lung Neoplasms, Wearable Electronic Devices, Exercise, Quality of Life. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Emerging evidence suggests that wearable devices are feasible for monitoring physical activity among patients with lung cancer. However, the association between wearable devices and improvement in patient recovery after surgery remains underexplored.

Objective

To evaluate the effects of a wearable device intervention on the recovery of physical activity, cardiopulmonary function, and health-related quality of life (HRQOL) after lung cancer surgery. Design, Setting, and Participants This nonrandomized clinical trial with a historical control was conducted at a single tertiary cancer center (Samsung Comprehensive Cancer Center) in Seoul, South Korea, between October 18, 2018, and May 24, 2019. Patients were included if they had suspected or confirmed non–small cell lung cancer scheduled for curative surgery more extensive than lobectomy and had an Eastern Cooperative Oncology Group status of 0 or 1. Patients were compared with historical control participants from data collected between September 20, 2017, and September 10, 2018, as part of the Coordinated Approach to Cancer Patients’ Health for Lung Cancer (CATCH-LUNG) prospective cohort study. Data analysis was performed between June 21 and July 16, 2020.

Intervention

A personalized exercise regimen monitored via a wearable device was administered to intervention patients at home in 3 stages: preoperative (from diagnosis to surgery), immediate (from discharge to 2 months after surgery), and later postoperative (from 2 to 6 months after surgery). Control patients received usual care. Main Outcomes and Measures The primary outcome was cardiopulmonary function, and the co–primary outcome was physical activity at 6 months after surgery, measured with 6-minute walking distance (6MWD) and number of daily steps, using a linear regression model. Secondary outcomes were changes in cardiopulmonary function, physical activity, and HRQOL, including function and symptoms from baseline to 2 weeks and 6 months after surgery. Additionally, cardiopulmonary function and physical activity (number of daily steps and time spent on moderate-to-vigorous physical activity [MVPA]) at 2 weeks after surgery, physical activity (time spent on MVPA) at 6 months after surgery, and HRQOL, including function and symptoms at 2 weeks and 6 months after surgery, were assessed as secondary outcomes.

Results

This trial included 74 patients in the intervention group (mean [SD] age, 60.4 [8.7] years; 31 [41.9%] men and 43 [58.1%] women) and 120 in the control group (mean [SD] age, 60.2 [8.7] years; 65 [54.2%] men and 55 [45.8%] women). Daily steps, MVPA, and 6MWD decreased initially at 2 weeks after surgery but increased thereafter. The control group had a larger decrease in the number of daily steps from baseline compared with the intervention group (−4877 [95% CI, −5861 to −3893] steps vs −1753 [95% CI, −2968 to −539] steps) at 2 weeks after surgery. By 6 months after surgery, the intervention group increased their daily steps by 2220 (95% CI, 1006 to 3435) from baseline, whereas the control group did not return to their baseline number of steps. The intervention group had significantly more daily steps (12 321 [95% CI, 8749-15 761] vs 10 118 [95% CI, 7341-13 420]; P = .007) and had greater vigorous physical activity (33.6 [95% CI, 13.5 to 59.8] vs 18.5 [5.7 to 40.8] minutes; P = .003) at 6 months after surgery compared with the control group. No difference in 6MWD was found. However, the intervention group had better patient-reported physical function (mean [SD] score, 82.2 [17.3] vs 76.9 [17.5]; P = .04), less dyspnea (mean [SD] score, 24.8 [27.1] vs 34.5 [31.6]; P = .03), and less pain (mean [SD] score, 21.4 [20.2] vs 30.1 [26.8]; P = .01) at 2 weeks after surgery and less dyspnea (mean [SD] score, 5.4[12.4] vs 12[23.3]; P = .01) at 6 months after surgery compared with the control group. Conclusions and Relevance In this nonrandomized clinical trial, integration of perioperative exercise interventions using wearable devices improved physical activity (especially MVPA) and dyspnea at 6 months after lung cancer surgery compared with usual care. This finding suggests a promising role for wearable devices in personalizing perioperative rehabilitation strategies. Trial Registration ClinicalTrials.gov Identifier: NCT03215537

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lung NeoplasmsWearable Electronic DevicesExerciseQuality of LifeHumansMaleFemaleMiddle AgedAgedProspective StudiesRepublic of KoreaCarcinoma, Non-Small-Cell Lung

Autor:innen und Institutionen

  • Department of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
  • Department of Clinical Research Design and Evaluation, Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, South Korea.
  • Patient-Centered Outcomes Research Institute, Samsung Medical Center, Seoul, South Korea.
  • Department of Thoracic and Cardiovascular Surgery, College of Medicine, Ewha Womans University Mokdong Hospital, Seoul, South Korea.
  • Trend Sensing and Risk Modeling Center, Institution of Quality of Life in Cancer, Samsung Medical Center, Seoul, South Korea.
  • Center for Clinical Epidemiology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Zitieren

APA

Lee, J., Kong, S., Shin, S., Lee, G., Kim, H. K., Shim, Y. M., Cho, J., Kang, D., & Park, H. Y. (2024). Wearable Device–Based Intervention for Promoting Patient Physical Activity After Lung Cancer Surgery. JAMA Network Open, 7(9), e2434180. https://doi.org/10.1001/jamanetworkopen.2024.34180

Vancouver

Lee J, Kong S, Shin S, Lee G, Kim HK, Shim YM, et al. Wearable Device–Based Intervention for Promoting Patient Physical Activity After Lung Cancer Surgery. JAMA Network Open. 2024;7(9):e2434180. doi:10.1001/jamanetworkopen.2024.34180

BibTeX
@article{Lee2024,
  author = {Lee, Junghee and Kong, Sunga and Shin, Sumin and Lee, Genehee and Kim, Hong Kwan and Shim, Young Mog and Cho, Juhee and Kang, Danbee and Park, Hye Yun},
  title = {Wearable Device–Based Intervention for Promoting Patient Physical Activity After Lung Cancer Surgery},
  journal = {JAMA Network Open},
  year = {2024},
  volume = {7},
  number = {9},
  pages = {e2434180},
  doi = {10.1001/jamanetworkopen.2024.34180}
}
Kostenlos starten →